治疗方案-话题@MedSci

#治疗方案#

313篇内容 | 3022人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1905218, encodeId=bb311905218cd, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=一文速览：乳腺癌常用药物及治疗方案大盘点, objectType=article, longId=737211, objectId=5b7ee37211e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b7ee37211e8, replyNumber=0, likeNumber=105, createdTime=2022-09-26, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b7ee37211e8, moduleTitle=一文速览：乳腺癌常用药物及治疗方案大盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b7ee37211e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905217, encodeId=72a6190521e4d, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=小细胞肺癌，国内外治疗方案大比拼（2022.2版）, objectType=article, longId=729295, objectId=7ef2e292953d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ef2e292953d, replyNumber=0, likeNumber=155, createdTime=2022-09-30, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ef2e292953d, moduleTitle=小细胞肺癌，国内外治疗方案大比拼（2022.2版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ef2e292953d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905198, encodeId=75b41905198d5, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Ther Adv Med Oncol：北京协和医院团队真实世界探索HER2改变的晚期NSCLC患者更佳一线治疗方案, objectType=article, longId=300517, objectId=5c7c30051ed6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c7c30051ed6, replyNumber=0, likeNumber=97, createdTime=2023-01-29, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c7c30051ed6, moduleTitle=Ther Adv Med Oncol：北京协和医院团队真实世界探索HER2改变的晚期NSCLC患者更佳一线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c7c30051ed6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905197, encodeId=b975190519eaf, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Rheumatology：FREE-J研究中类风湿关节炎缓解期患者基于共同决策的治疗方案选择, objectType=article, longId=299675, objectId=82992996e5c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82992996e5c3, replyNumber=0, likeNumber=148, createdTime=2022-08-06, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82992996e5c3, moduleTitle=Rheumatology：FREE-J研究中类风湿关节炎缓解期患者基于共同决策的治疗方案选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82992996e5c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2092792, encodeId=8fc02092e9244, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小细胞肺癌#</a><a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a><a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a>，现在主要看<a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a>和<a href='/topic/show?id=c31310491053' target=_blank style='color:#2F92EE;'>#鲁比卡丁#</a>这一类新药，虽然整体疗效仍然不理想。, objectTitle=小细胞肺癌，国内外治疗方案大比拼（2022.2版）, objectType=article, longId=729295, objectId=7ef2e292953d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201230/1609342591541_2020535.jpg, objectUrl=/article/show_article.do?id=7ef2e292953d, replyNumber=0, likeNumber=223, createdTime=2022-10-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ef2e292953d, moduleTitle=小细胞肺癌，国内外治疗方案大比拼（2022.2版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ef2e292953d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905183, encodeId=eb66190518308, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Aesthetic Plast Surg ：隆胸患者植入物相关感染的治疗方案选择, objectType=article, longId=218394, objectId=5a1a218394cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a1a218394cf, replyNumber=0, likeNumber=113, createdTime=2021-11-30, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a1a218394cf, moduleTitle=Aesthetic Plast Surg ：隆胸患者植入物相关感染的治疗方案选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a1a218394cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905203, encodeId=d0c9190520376, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Cancer：ER阳性低表达（IHC 1%-10%）乳腺癌患者短程（2-3年）辅助内分泌治疗是可选择的治疗方案, objectType=article, longId=723583, objectId=9000e235839c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9000e235839c, replyNumber=0, likeNumber=93, createdTime=2022-06-03, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9000e235839c, moduleTitle=Cancer：ER阳性低表达（IHC 1%-10%）乳腺癌患者短程（2-3年）辅助内分泌治疗是可选择的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9000e235839c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905207, encodeId=a789190520e83, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=NEJM：循环肿瘤DNA分析用于II期结肠癌患者术后治疗方案决策, objectType=article, longId=729745, objectId=43d8e29745b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43d8e29745b7, replyNumber=0, likeNumber=123, createdTime=2023-03-01, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43d8e29745b7, moduleTitle=NEJM：循环肿瘤DNA分析用于II期结肠癌患者术后治疗方案决策, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43d8e29745b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905212, encodeId=ee4419052129d, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=生物制剂治疗方案的安全管理：治疗前筛查与治疗后监测, objectType=article, longId=734256, objectId=3e9be342563e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e9be342563e, replyNumber=0, likeNumber=99, createdTime=2023-06-03, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e9be342563e, moduleTitle=生物制剂治疗方案的安全管理：治疗前筛查与治疗后监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e9be342563e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905195, encodeId=1aeb190519589, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=糖尿病或可逆转！异种移植会成为解决I型糖尿病的终极治疗方案吗？, objectType=article, longId=294295, objectId=64f629429562, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64f629429562, replyNumber=0, likeNumber=83, createdTime=2022-07-14, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64f629429562, moduleTitle=糖尿病或可逆转！异种移植会成为解决I型糖尿病的终极治疗方案吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64f629429562)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905181, encodeId=d63a190518168, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=肾上腺皮质癌有适合的治疗方案吗？, objectType=article, longId=217544, objectId=3ad421e544bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ad421e544bc, replyNumber=0, likeNumber=68, createdTime=2022-01-25, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ad421e544bc, moduleTitle=肾上腺皮质癌有适合的治疗方案吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ad421e544bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905209, encodeId=7ea8190520975, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=高血压合并肾病，治疗方案如何选？, objectType=article, longId=733256, objectId=101ce33256b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=101ce33256b2, replyNumber=0, likeNumber=98, createdTime=2022-09-04, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=101ce33256b2, moduleTitle=高血压合并肾病，治疗方案如何选？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=101ce33256b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905192, encodeId=9c49190519266, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JAMA Netw Open：中肿麦海强教授团队证实奈达铂为基础的同期放化疗可作为II-IVB期鼻咽癌患者的有效治疗方案, objectType=article, longId=292561, objectId=7ac929256113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ac929256113, replyNumber=0, likeNumber=82, createdTime=2022-04-02, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ac929256113, moduleTitle=JAMA Netw Open：中肿麦海强教授团队证实奈达铂为基础的同期放化疗可作为II-IVB期鼻咽癌患者的有效治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ac929256113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905205, encodeId=9e4f190520514, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Oncol：转移性肾透明细胞癌的三种一线治疗方案的疗效和安全性, objectType=article, longId=723824, objectId=cc6fe23824f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc6fe23824f3, replyNumber=0, likeNumber=96, createdTime=2023-01-26, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc6fe23824f3, moduleTitle=Lancet Oncol：转移性肾透明细胞癌的三种一线治疗方案的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc6fe23824f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905191, encodeId=95f81905191c9, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=肺源性心脏病可能并发左心功能不全吗？如何制定治疗方案？, objectType=article, longId=292305, objectId=16d6292305d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16d6292305d2, replyNumber=0, likeNumber=76, createdTime=2022-03-16, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16d6292305d2, moduleTitle=肺源性心脏病可能并发左心功能不全吗？如何制定治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16d6292305d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905206, encodeId=b18c190520684, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=AJKD：血液透析患者能接受更频繁、更长时间的治疗方案吗？有些患者表示：“太麻烦，我宁愿少活2年！”, objectType=article, longId=727480, objectId=88d5e27480ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88d5e27480ad, replyNumber=0, likeNumber=83, createdTime=2022-05-25, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88d5e27480ad, moduleTitle=AJKD：血液透析患者能接受更频繁、更长时间的治疗方案吗？有些患者表示：“太麻烦，我宁愿少活2年！”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88d5e27480ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905179, encodeId=4ce619051e986, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！, objectType=article, longId=216219, objectId=7cde216219cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cde216219cc, replyNumber=0, likeNumber=83, createdTime=2022-01-09, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cde216219cc, moduleTitle=Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cde216219cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905193, encodeId=cebf1905193fb, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=非小细胞肺癌，国内外治疗方案大比拼（2022.1版）, objectType=article, longId=292833, objectId=c17f29283359, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c17f29283359, replyNumber=0, likeNumber=87, createdTime=2022-03-30, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c17f29283359, moduleTitle=非小细胞肺癌，国内外治疗方案大比拼（2022.1版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c17f29283359)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905200, encodeId=9cda190520089, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Clin Oncol：国内多中心III期研究表明局部进展期直肠癌术前短程放疗+化疗（TNT）是可行的治疗方案, objectType=article, longId=300860, objectId=e92c300860d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e92c300860d9, replyNumber=0, likeNumber=145, createdTime=2022-09-20, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e92c300860d9, moduleTitle=J Clin Oncol：国内多中心III期研究表明局部进展期直肠癌术前短程放疗+化疗（TNT）是可行的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e92c300860d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905202, encodeId=341519052022b, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JAMA：3种杜氏肌营养不良皮质类固醇治疗方案的疗效及安全性差异, objectType=article, longId=723648, objectId=c6c3e23648cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6c3e23648cc, replyNumber=0, likeNumber=78, createdTime=2022-09-30, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6c3e23648cc, moduleTitle=JAMA：3种杜氏肌营养不良皮质类固醇治疗方案的疗效及安全性差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6c3e23648cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗方案

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

一文速览：乳腺癌常用药物及治疗方案大盘点

2022-09-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

小细胞肺癌，国内外治疗方案大比拼（2022.2版）

2022-09-30

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Ther Adv Med Oncol：北京协和医院团队真实世界探索HER2改变的晚期NSCLC患者更佳一线治疗方案

2023-01-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Rheumatology：FREE-J研究中类风湿关节炎缓解期患者基于共同决策的治疗方案选择

2022-08-06

lifestar (审核中...)

前往app查看评论内容

#小细胞肺癌##治疗方案##肺癌#，现在主要看#免疫治疗#和#鲁比卡丁#这一类新药，虽然整体疗效仍然不理想。

小细胞肺癌，国内外治疗方案大比拼（2022.2版）

2022-10-10

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Aesthetic Plast Surg ：隆胸患者植入物相关感染的治疗方案选择

2021-11-30

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Cancer：ER阳性低表达（IHC 1%-10%）乳腺癌患者短程（2-3年）辅助内分泌治疗是可选择的治疗方案

2022-06-03

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

NEJM：循环肿瘤DNA分析用于II期结肠癌患者术后治疗方案决策

2023-03-01

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

生物制剂治疗方案的安全管理：治疗前筛查与治疗后监测

2023-06-03

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

糖尿病或可逆转！异种移植会成为解决I型糖尿病的终极治疗方案吗？

2022-07-14

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

肾上腺皮质癌有适合的治疗方案吗？

2022-01-25

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

高血压合并肾病，治疗方案如何选？

2022-09-04

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JAMA Netw Open：中肿麦海强教授团队证实奈达铂为基础的同期放化疗可作为II-IVB期鼻咽癌患者的有效治疗方案

2022-04-02

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Oncol：转移性肾透明细胞癌的三种一线治疗方案的疗效和安全性

2023-01-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

肺源性心脏病可能并发左心功能不全吗？如何制定治疗方案？

2022-03-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

AJKD：血液透析患者能接受更频繁、更长时间的治疗方案吗？有些患者表示：“太麻烦，我宁愿少活2年！”

2022-05-25

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！

2022-01-09

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

非小细胞肺癌，国内外治疗方案大比拼（2022.1版）

2022-03-30

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Clin Oncol：国内多中心III期研究表明局部进展期直肠癌术前短程放疗+化疗（TNT）是可行的治疗方案

2022-09-20

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JAMA：3种杜氏肌营养不良皮质类固醇治疗方案的疗效及安全性差异

2022-09-30

科室
- - 订阅+
  - 更多科室
工具
服务